BeStock  

Medline MDLN

US equityMarket cap rank #440Medical Instruments & Supplies
$34.45 −$0.25 (-0.72%)
Market open · Oct 1, 11:50 am ET · After hours $34.80 +0.29%
Open$34.85
Prev close$34.70
Day range$34.14 – $35.29
Volume2.05M
Market cap$30.22B
P/E (TTM)65.4
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$7.69B+11.6% YoY
Operating profit$395.00M-38.5% YoY
Net profit$139.00M-58.3% YoY
Diluted EPS$0.07-83.2% YoY
Free cash flow$604.00M+594.3% YoY
Operating cash flow$715.00M

Revenue, last 8 quarters

$6.4BSep '24$6.8BDec '24$6.6BMar '25$6.9BJun '25$7.1BSep '25$7.8BDec '25$7.4BMar '26$7.7BJun '26

Net profit, last 8 quarters

$324.0MSep '24$289.0MDec '24$322.0MMar '25$333.0MJun '25$322.0MSep '25$180.0MDec '25$239.0MMar '26$139.0MJun '26

Diluted EPS by quarter

0.18Sep '240.16Dec '240.18Mar '250.42Jun '250.18Sep '25-0.01Dec '250.16Mar '260.07Jun '26

Free cash flow by quarter

$615.0MSep '24$-164.0MDec '24$584.0MMar '25$87.0MJun '25$535.0MSep '25$91.0MDec '25$316.0MMar '26$604.0MJun '26

Annual revenue

$21.4BFY22$23.2BFY23$25.5BFY24$28.4BFY25

Profitability & balance sheet

Gross margin26.2%
Operating margin6.1%
Net margin2.3%
Return on equity12.0%
Return on assets1.9%
Return on invested capital6.0%
Current ratio4.33
Liabilities / assets51.5%
Cash & investments$2.68B
Total debt$12.58B
Net cash (debt)-$9.90B
Free cash flow / sales5.2%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $7.69B $7.35B $28.43B $7.79B $7.12B
Total Operating Revenue $7.69B $7.35B $28.43B $7.79B $7.12B
Cost of Revenue $5.47B $5.51B $20.91B $5.87B $5.24B
Gross Profit $2.22B $1.84B $7.52B $1.91B $1.88B
Operating Expense $1.82B $1.42B $5.31B $1.49B $1.30B
Selling and Admin Expenses $1.30B $1.23B $4.52B $1.27B $1.12B
Depreciation & Amortization & Depletion $177.00M $176.00M $704.00M $176.00M $177.00M
-Depreciation & Amortization $177.00M $176.00M $704.00M $176.00M $177.00M
Other Operating Expenses $348.00M $15.00M $78.00M $48.00M $8.00M
Operating Profit $395.00M $422.00M $2.21B $425.00M $574.00M
Net Non-Operating Interest Income (Expense) -$119.00M -$136.00M -$812.00M -$166.00M -$213.00M
Non-Operating Interest Income $49.00M $29.00M – – –
Non-Operating Interest Expense $168.00M $165.00M $812.00M $166.00M $213.00M
Other Income (Expense) -$41.00M $5.00M -$152.00M -$53.00M -$16.00M
Gain on Sale of Security $1.00M $4.00M -$88.00M $5.00M -$10.00M
Other Non-Operating Income (Expenses) -$42.00M $1.00M -$64.00M -$58.00M -$6.00M
Pretax Profit $235.00M $291.00M $1.25B $206.00M $345.00M
Tax $96.00M $52.00M $91.00M $26.00M $23.00M
Net Profit $139.00M $239.00M $1.16B $180.00M $322.00M
Profit from Continuing Operations $139.00M $239.00M $1.16B $180.00M $322.00M
Minority Interests $79.00M $110.00M -$2.00M – –
Net Income to Parent Company $60.00M $129.00M $1.16B $182.00M $322.00M
Other Preferred Stock Dividends $1.00M -$3.00M – – –
Net Income to Common Stockholders $59.00M $132.00M $1.16B $182.00M $322.00M
Basic EPS $0.07 $0.16 $1.43 -$0.01 $0.18
Diluted EPS $0.07 $0.16 $1.43 -$0.01 $0.18

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $39.35B $39.01B $38.48B $38.48B $36.88B
Total Current Assets $11.74B $11.18B $10.68B $10.68B $9.56B
Cash and Cash Equivalents & Short-Term Investments $2.68B $2.24B $1.94B $1.94B $952.00M
-Cash and Cash Equivalents $2.33B $2.24B $1.94B $1.94B $952.00M
-Short Term Investments $350.00M – – – –
Receivables $3.66B $3.67B $3.53B $3.53B $3.43B
-Accounts Receivable $3.66B $3.67B $3.53B $3.53B $3.43B
Inventory $4.67B $4.81B $4.77B $4.77B $4.75B
Other Current Assets $739.00M $463.00M $438.00M $438.00M $429.00M
Total Non-Current Assets $27.61B $27.83B $27.81B $27.81B $27.33B
Net PPE $4.70B $4.76B $4.78B $4.78B $4.69B
Goodwill and Other Intangible Assets $21.61B $21.79B $21.97B $21.97B $22.14B
-Goodwill $8.07B $8.08B $8.08B $8.08B $8.07B
-Other Intangible Assets $13.54B $13.72B $13.89B $13.89B $14.07B
Non-Current Deferred Assets $866.00M $837.00M $583.00M $583.00M –
Other Non-Current Assets $435.00M $446.00M $472.00M $472.00M $498.00M
Total Liabilities $20.27B $19.67B $19.20B $19.20B $19.74B
Total Current Liabilities $2.71B $2.54B $2.49B $2.49B $2.61B
Payables $1.14B $1.05B $1.07B $1.07B $1.10B
-Accounts Payable $1.04B $932.00M $961.00M $961.00M $990.00M
-Total Tax Payable $93.00M $121.00M $111.00M $111.00M $114.00M
Current Accrued Expenses $968.00M $941.00M $873.00M $873.00M $980.00M
Short-Term Debt and Capital Lease Obligation $92.00M $142.00M $143.00M $143.00M $149.00M
-Current Debt $29.00M $77.00M $77.00M $77.00M $77.00M
-Current Capital Lease Obligation $63.00M $65.00M $66.00M $66.00M $72.00M
Other Current Liabilities $514.00M $400.00M $402.00M $402.00M $379.00M
Total Non-Current Liabilities $17.56B $17.13B $16.71B $16.71B $17.13B
Long Term Debt and Capital Lease Obligation $12.55B $12.50B $12.48B $12.48B $16.50B
-Long Term Debt $12.55B $12.50B $12.48B $12.48B $16.50B
Other Non-Current Liabilities $5.02B $4.63B $4.22B $4.22B $629.00M
Total Equity $19.08B $19.35B $19.29B $19.29B $17.14B
Stockholders' Equity $11.57B $11.27B $10.74B $10.74B –
Capital Stock $0.00 $0.00 $0.00 $0.00 –
-Common Stock $0.00 $0.00 $0.00 $0.00 –
-Preferred Stock $0.00 $0.00 $0.00 $0.00 –
Additional Paid-In Capital $11.40B $11.13B $10.72B $10.72B –
Retained Earnings $182.00M $122.00M -$7.00M -$7.00M –
Gains/Losses Not Affecting Retained Earnings -$6.00M $18.00M $27.00M $27.00M –
Minority Interests $7.51B $8.08B $8.55B $8.55B –
Share capital – – – – $17.01B

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $715.00M $412.00M $1.74B $229.00M $636.00M
Net cash flow from continuing operations $715.00M $412.00M $1.74B $229.00M $636.00M
Net Income from Continuing Operations $139.00M $239.00M $1.16B $180.00M $322.00M
Gain/Loss from Continuing Operations $18.00M -$12.00M $85.00M -$18.00M $9.00M
Depreciation & Depletion & Amortization $256.00M $254.00M $1.01B $261.00M $253.00M
Deferred Tax $64.00M $37.00M – – –
Other Non-Cash Items $366.00M $31.00M $144.00M $52.00M $23.00M
Change in Working Capital -$163.00M -$161.00M -$783.00M -$282.00M $1.00M
-Change in Receivables -$2.00M -$146.00M -$355.00M -$116.00M -$90.00M
-Change in Inventory -$74.00M -$42.00M -$264.00M -$15.00M -$89.00M
-Change in Payables and Accrued Expense $202.00M $78.00M -$19.00M -$142.00M $252.00M
-Change in Other Current Assets -$278.00M -$19.00M -$126.00M -$2.00M -$81.00M
-Change in Other Current Liabilities -$11.00M -$32.00M -$19.00M -$7.00M $9.00M
Net cash flow from investing -$461.00M -$96.00M -$474.00M -$138.00M -$101.00M
Net Cash Flow from Continuing Investing Activities -$461.00M -$96.00M -$474.00M -$138.00M -$101.00M
Net PPE Purchase and Sale -$111.00M -$96.00M -$447.00M -$138.00M -$101.00M
Net Business Purchase and Sale $0.00 $0.00 $6.00M $0.00 $0.00
Financing Cash Flow -$159.00M -$13.00M $399.00M $897.00M -$161.00M
Net Cash Flow from Continuing Financing Activities -$159.00M -$13.00M $399.00M $897.00M -$161.00M
Net Issuance Payments Of Debt -$38.00M $0.00 -$4.09B -$4.05B -$24.00M
Net Common Stock Issuance $0.00 $0.00 $5.05B $5.08B -$18.00M
Net Other Financing Charges -$122.00M -$13.00M -$36.00M – –
Ending Cash Balance $2.33B $2.24B $1.94B $1.94B $955.00M
Net Change in Cash $95.00M $303.00M $1.67B $988.00M $374.00M
Beginning Cash Balance $2.24B $1.94B $250.00M $955.00M $584.00M
Effect of Exchange Rate Changes -$4.00M -$7.00M $23.00M -$1.00M -$3.00M
Free Cash Flow $604.00M $316.00M $1.30B $91.00M $535.00M
Net Other Investing Changes – – -$33.00M $0.00 $0.00
Cash Dividends Paid – – -$518.00M -$96.00M -$119.00M

Discussion

No comments yet — be the first to weigh in on MDLN.

Leave a comment

Scroll to Top